Get a glimpse into our company and investor data—powered by the PitchBook Platform
Developer of products for the management of diabetes. The company is the developer of a continuous glucose monitoring system for blood sugar and pen needles for administration of insulin.
This information is reserved for PitchBook Platform users. To explore Nintamed‘s full profile, request access.
© 2020 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.